---
layout: minimal-medicine
title: Florbetapir F 18
---

# Florbetapir F 18
### Generic Name
Florbetapir F 18

### Usage

Florbetapir F 18 is a radioactive tracer used in Positron Emission Tomography (PET) brain scans.  Its primary purpose is to help estimate the density of beta-amyloid neuritic plaques in adults experiencing cognitive impairment.  This helps in the evaluation of Alzheimer's disease (AD) and other conditions causing cognitive decline.  The scan acts as an adjunct to other diagnostic tests, not as a standalone diagnostic tool for AD itself.  It aids in differentiating AD from other potential causes of cognitive issues.

### Dosage

**Beta-amyloid plaque estimation (Adults):**

*   A single intravenous bolus injection of 370 MBq (10 mCi), with a maximum mass dose of 50 micrograms, in a volume of 10 mL or less.
*   Follow the injection with a saline flush.
*   The injection should be given through a short intravenous catheter (approximately 1.5 inches or less) to minimize drug adsorption.
*   The dose should be checked using a dose calibrator before administration.
*   A PET scan is typically acquired 30-50 minutes post-injection.

**Pediatric Dosage:** Florbetapir F 18 is not approved for use in children.

**Dosage Adjustments:** The manufacturer's labeling does not provide dosage adjustments for hepatic or renal impairment.

### Side Effects

**Common (1-10%):**

*   Headache

**Less Common (<1%):**

*   Anxiety
*   Back pain
*   Claustrophobia
*   Dizziness
*   Dysgeusia (altered taste)
*   Fatigue
*   Flushing
*   Increased blood pressure
*   Injection site reactions (hemorrhage, irritation, pain)
*   Insomnia
*   Musculoskeletal pain
*   Nausea
*   Neck pain
*   Pruritus (itching)
*   Rash at the injection site
*   Sensation of cold
*   Urticaria (hives)


If you experience any adverse effects, consult your healthcare provider immediately.

### How it Works

Florbetapir F 18 is a radiotracer that binds to beta-amyloid plaques, which are characteristic of Alzheimer's disease and other neurological conditions. The radioactive fluorine-18 isotope in the tracer emits positrons. These positrons are detected by the PET scanner, creating an image that shows the distribution of beta-amyloid plaques in the brain. Higher concentrations of the tracer indicate a greater density of these plaques.

### Precautions

* **Pregnancy and Lactation:** Florbetapir F 18 is categorized as Pregnancy Category C.  Pregnancy status should be assessed before administration.  Radiopharmaceuticals can potentially harm a fetus. The effects of breastfeeding after administration are unknown; appropriate precautions (e.g., pumping and discarding breast milk) should be considered.
* **Other Precautions:** Florbetapir F 18 is a radiopharmaceutical; handle and dispose of it using appropriate safety measures.  Qualified personnel trained in handling radioactive materials should administer it. Image interpretation requires expertise and should be considered alongside other clinical information.  The scan provides an estimate of plaque density; it does not provide a definitive diagnosis of any condition.

### FAQs

* **Q: Is Florbetapir F 18 a cure for Alzheimer's disease?**  A: No, it is a diagnostic imaging agent; it does not treat or cure Alzheimer's or any other disease.

* **Q: How long does the scan take?** A: The image acquisition itself takes approximately 10 minutes, starting 30-50 minutes after injection. The overall procedure may take longer.

* **Q: Are there any special preparations needed before the scan?** A: Your doctor will provide specific instructions, but generally, you might be asked to fast or avoid certain foods or drinks before the scan.

* **Q: What does a positive or negative scan mean?** A: A positive scan shows moderate to frequent amyloid plaques, suggesting the possibility of AD or another condition involving amyloid buildup.  A negative scan indicates sparse or no plaques, making AD less likely.  However, neither result definitively confirms or rules out a diagnosis.  Clinical evaluation remains critical.

* **Q: How is the medication stored?** A:  Florbetapir F 18 is a radiopharmaceutical and must be stored and handled according to strict guidelines provided by the manufacturer and relevant regulatory authorities.


**Disclaimer:** This information is intended for general knowledge and does not constitute medical advice. Always consult your healthcare provider for any health concerns or before making any decisions related to your health or treatment.  The information provided here is based on currently available information and may be subject to change.
